Quest Health gets new backing
![Default Author Head Shot](/uploads/userfiles/files/images/blog/default-staff-image.jpg)
By HME News Staff
Updated 11:17 AM CDT, Wed July 17, 2024
NEW YORK & CORAL SPRINGS, Fla. – Sumitomo Corp. has made an investment in Vast Medical Holdings, the parent company of Quest Health Solutions, a provider of continuous glucose monitors and other diabetes supplies.
Quest Health, through its sister companies Quest Health Remote Care and Quest Health RPM Services, integrates CGM data with clinical support such as patient education, meal planning and exercise guidance to improve health outcomes.
“The confidence shown by Sumitomo, and its alignment with our vision for the industry, adds tremendous momentum to our growth plans,” said Adam Nadler, CEO and co-founder of Quest. “Finding a partner who believes in our model was critical to our priorities and our quest for continued improvement in patient care.
The transaction marks Sumitomo’s entry into the U.S. health care market and expands its network of health insurers and medical institutions.
“We have found an ideal partner to mark our entry into the U.S. health care market,” said Jeremy Yap, general manager of the Healthcare Group and Business Development Group at Sumitomo. “The scope of Quest Health Solutions operations aligns well with our business strategy and supports our focus on improving health outcomes and providing greater access to health care resources.”
Comments